Intrahepatic Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Intrahepatic Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-23Clinical Trial Update: Treat Primary and Metastatic Liver Tumors
Clinical trial NCT05240040 sponsored by Methodist Health System has been withdrawn; it concerns the treatment of intrahepatic cholangiocarci…
-
CLINICAL_TRIALS withdrawal · 2025-06-29Clinical Trial Update: The Safety and Efficacy of CD-801 in Patients With Advanced Intrahepatic Cholangiocarcinoma [EARLY_Phase 1]
An early-phase 1 trial of CD-801 for advanced intrahepatic cholangiocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-05Clinical Trial Update: Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies [Phase 4]
A Phase 4 trial assessing the Surefire Infusion Device in regional intra-arterial therapy for primary liver malignancies has been withdrawn.…
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 neoadjuvant trial of tremelimumab and durvalumab with gemcitabine/cisplatin for intrahepatic cholangiocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-02-19Clinical Trial Update: A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma [Phase 3]
A Phase 3 trial evaluating cisplatin or carboplatin with gemcitabine versus gemcitabine alone as adjuvant therapy in intrahepatic cholangioc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-04-18Clinical Trial Update: Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery [Phase 1]
A Phase 1 trial of Capecitabine plus Y-90 radioembolization for advanced intrahepatic cholangiocarcinoma (bile duct cancer) that cannot be s…
-
CLINICAL_TRIALS withdrawal · 2015-06-09Clinical Trial Update: Response of Hepatic Tumors to Radioembolization [Phase 2]
Phase 2 trial evaluating hepatic tumors (hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and liver metastases) after radioemboliz…